Increased glycolysis correlates with elevated immune activity in tumor immune microenvironment

Ribas, 2018, Cancer immunotherapy using checkpoint blockade, Science, 359, 1350, 10.1126/science.aar4060 June, 2018, CAR T cell immunotherapy for human cancer, Science, 359, 1361, 10.1126/science.aar6711 Braun, 2016, Genomic approaches to understanding response and resistance to immunotherapy, Clin Cancer Res, 22, 5642, 10.1158/1078-0432.CCR-16-0066 Zhao, 2018, Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients' preference-based study (PPPS), Clin Transl Oncol, 10.1007/s12094-018-1968-3 Kang, 2016, Current clinical trials testing the combination of immunotherapy with radiotherapy, J Immunother Cancer, 4, 51, 10.1186/s40425-016-0156-7 Moya-Horno, 2018, Combination of immunotherapy with targeted therapies in advanced non-small cell lung cancer (NSCLC), Ther Adv Med Oncol, 10, 10.1177/1758834017745012 Goel, 2017, CDK4/6 inhibition triggers anti-tumour immunity, Nature, 548, 471, 10.1038/nature23465 Patel, 2015, PD-L1 expression as a predictive biomarker in cancer immunotherapy, Mol Cancer Ther, 14, 847, 10.1158/1535-7163.MCT-14-0983 Goodman, 2017, Tumor mutational burden as an independent predictor of response to immunotherapy in diverse cancers, Mol Cancer Ther, 16, 2598, 10.1158/1535-7163.MCT-17-0386 Yarchoan, 2017, Targeting neoantigens to augment antitumour immunity, Nat Rev Cancer, 17, 209, 10.1038/nrc.2016.154 Xiao, 2015, The microsatellite instable subset of colorectal cancer is a particularly good candidate for checkpoint blockade immunotherapy, Cancer Discov, 5, 16, 10.1158/2159-8290.CD-14-1397 Davoli, 2017, Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy, Science, 355 Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 Warburg, 1927, The metabolism of tumors in the body, J Gen Physiol, 8, 519, 10.1085/jgp.8.6.519 Chang, 2015, Metabolic competition in the tumor microenvironment is a driver of cancer progression, Cell, 162, 1229, 10.1016/j.cell.2015.08.016 Cascone, 2018, Increased tumor glycolysis characterizes immune resistance to adoptive T cell therapy, Cell Metab, 27, 977, 10.1016/j.cmet.2018.02.024 Subramanian, 2005, Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc Natl Acad Sci U S A, 102, 15545, 10.1073/pnas.0506580102 Yoshihara, 2013, Inferring tumour purity and stromal and immune cell admixture from expression data, Nat Commun, 4, 2612, 10.1038/ncomms3612 Barbie, 2009, Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1, Nature, 462, 108, 10.1038/nature08460 Hanzelmann, 2013, GSVA: gene set variation analysis for microarray and RNA-seq data, BMC Bioinformatics, 14, 7, 10.1186/1471-2105-14-7 Carter, 2012, Absolute quantification of somatic DNA alterations in human cancer, Nat Biotechnol, 30, 413, 10.1038/nbt.2203 Liu, 2018, A comprehensive immunologic portrait of triple-negative breast cancer, Transl Oncol, 11, 311, 10.1016/j.tranon.2018.01.011 Massink, 2015, Genomic profiling of CHEK2*1100delC-mutated breast carcinomas, BMC Cancer, 15, 877, 10.1186/s12885-015-1880-y Rooney, 2015, Molecular and genetic properties of tumors associated with local immune cytolytic activity, Cell, 160, 48, 10.1016/j.cell.2014.12.033 Kanehisa, 2017, KEGG: new perspectives on genomes, pathways, diseases and drugs, Nucleic Acids Res, 45, D353, 10.1093/nar/gkw1092 Hugo, 2016, Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma, Cell, 165, 35, 10.1016/j.cell.2016.02.065 Nathanson, 2017, Somatic mutations and neoepitope homology in melanomas treated with CTLA-4 blockade, Cancer Immunol Res, 5, 84, 10.1158/2326-6066.CIR-16-0019 Christofk, 2008, The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth, Nature, 452, 230, 10.1038/nature06734 Magistretti, 2015, A cellular perspective on brain energy metabolism and functional imaging, Neuron, 86, 883, 10.1016/j.neuron.2015.03.035 Rizvi, 2015, Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer, Science, 348, 124, 10.1126/science.aaa1348 Juneja, 2017, PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity, J Exp Med, 214, 895, 10.1084/jem.20160801